vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics
vTv Therapeutics Inc. - (VTVT)
Today's Latest Price: $2.77 USD
0.04 (1.47%)
Updated Feb 19 6:55pm
Add VTVT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VTVT Stock Summary
- vTv Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 6.09% of US listed stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -0.16 for vTv Therapeutics Inc; that's greater than it is for only 6% of US stocks.
- With a year-over-year growth in debt of -51.14%, vTv Therapeutics Inc's debt growth rate surpasses merely 5.98% of about US stocks.
- If you're looking for stocks that are quantitatively similar to vTv Therapeutics Inc, a group of peers worth examining would be CRIS, TROV, ADRO, ONTX, and HTBX.
- VTVT's SEC filings can be seen here. And to visit vTv Therapeutics Inc's official web site, go to www.vtvtherapeutics.com.
VTVT Daily Price Range
VTVT 52-Week Price Range
VTVT Stock Price Chart More Charts
VTVT Price/Volume Stats
| Current price | $2.77 | 52-week high | $4.23 |
| Prev. close | $2.73 | 52-week low | $1.23 |
| Day low | $2.52 | Volume | 644,200 |
| Day high | $2.95 | Avg. volume | 1,234,118 |
| 50-day MA | $2.07 | Dividend yield | N/A |
| 200-day MA | $1.61 | Market Cap | 149.95M |
vTv Therapeutics Inc. - (VTVT) Company Bio
vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.
Top Stories View All
3 Picks Set to Soar Because of Coronavirus
Best & Worst Performing Stock Industries for February 19, 2020
Best & Worst Performing Small Cap Stocks for February 19, 2020
Best & Worst Performing Mid Cap Stocks for February 19, 2020
Best & Worst Performing Large Cap Stocks for February 19, 2020
View All Top Stories
Loading social stream, please wait...